IGF-1/GH axis enhances losartan treatment in Lama2-related muscular dystrophy.
about
Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMDLinker proteins restore basement membrane and correct LAMA2-related muscular dystrophy in mice.Laminin-deficient muscular dystrophy: Molecular pathogenesis and structural repair strategies.The proximity-labeling technique BioID identifies sorting nexin 6 as a member of the insulin-like growth factor 1 (IGF1)-IGF1 receptor pathway.At the Crossroads of Clinical and Preclinical Research for Muscular Dystrophy-Are We Closer to Effective Treatment for Patients?
P2860
IGF-1/GH axis enhances losartan treatment in Lama2-related muscular dystrophy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
IGF-1/GH axis enhances losartan treatment in Lama2-related muscular dystrophy.
@en
type
label
IGF-1/GH axis enhances losartan treatment in Lama2-related muscular dystrophy.
@en
prefLabel
IGF-1/GH axis enhances losartan treatment in Lama2-related muscular dystrophy.
@en
P2093
P2860
P356
P1476
IGF-1/GH axis enhances losartan treatment in Lama2-related muscular dystrophy.
@en
P2093
Ajay Kumar
Alex Miller
Anthony Accorsi
Mahasweta Girgenrath
Younghwa Rhee
P2860
P304
P356
10.1093/HMG/DDW291
P577
2016-10-24T00:00:00Z